Extractables and Leachables Testing: A Practical Primer for Packaging Buyers
By the Green Medical Packing engineering team

Extractables and leachables — commonly abbreviated E&L — is one of the most frequently misunderstood areas of pharmaceutical packaging qualification. This primer sets out the framework and the practical decisions involved.
Extractables Versus Leachables
The two terms are closely related but distinct:
- Extractables are compounds that can be released from a packaging material under exaggerated laboratory conditions — elevated temperature, aggressive solvents, extended contact time.
- Leachables are compounds that actually migrate into the drug product under normal storage and use conditions.
Extractables studies are performed on the material itself. Leachables studies are performed on the finished drug product. The extractables study informs the design of the leachables study.
Regulatory Framework
In the United States, USP <1663> describes the assessment of extractables and USP <1664> the assessment of leachables. For plastic materials and systems, USP <661.1> and <661.2> set out material characterization and system suitability requirements respectively. In Europe, EP 3.1 and 3.2 chapters serve an equivalent role.
For orally inhaled and nasal drug products, and for certain sensitive applications, expectations are more demanding, and a formal toxicological risk assessment of identified leachables is normally required.
Study Design Choices
The main decisions in an extractables study are:
- Extraction solvents — typically polar, non-polar, and intermediate solvents to cover the range of potential extractables
- Extraction conditions — temperature and time, chosen to exaggerate normal contact but remain representative
- Analytical techniques — typically a combination of GC-MS for volatile and semi-volatile compounds and LC-MS for non-volatile compounds, plus elemental analysis where relevant
- Reporting threshold — the concentration above which peaks are identified and reported
The output is a list of identified extractables with concentrations under exaggerated conditions.
What Suppliers Can Provide
Material suppliers can support E&L work in several ways:
- Material composition information, including additives and processing aids
- Existing extractables data for standard materials and conditions
- Support in identifying peaks that correspond to known formulation components
- Change control commitments, so that a formulation change does not invalidate completed studies
Our technical documentation package, described on the certifications page, includes composition and compliance information for our product ranges. For materials requiring additional E&L support, our team can provide the formulation data your laboratory needs — contact us to discuss the requirement.
Timing Matters
E&L studies sit on the critical path for many submissions. Starting material selection and composition review early — before the study is commissioned — avoids the common situation where a late formulation change invalidates completed testing.
Have questions about this topic?
Send your pack format and target market — our technical team replies within 48 hours.
Recommended materials
Materials referenced in this article

HDPE Bottles for Oral Solid Preparation
High-density polyethylene bottles for tablets, capsules, and solid dosage forms
View specifications
PET Bottles for Oral Liquid Preparation
Clear and amber PET bottles for liquid pharmaceuticals with excellent clarity
View specifications
High-Barrier PVC Films
Advanced moisture and oxygen barrier for extended shelf life
View specifications

